share_log

JMP Securities Initiates Coverage On Ironwood Pharmaceuticals With Market Outperform Rating, Announces Price Target of $22

JMP Securities Initiates Coverage On Ironwood Pharmaceuticals With Market Outperform Rating, Announces Price Target of $22

JMP Securities啓動對Ironwood Pharmicals的報道,評級爲跑贏大盤,宣佈目標股價爲22美元
Benzinga ·  2023/09/28 05:55

JMP Securities analyst Jason Butler initiates coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Market Outperform rating and announces Price Target of $22.

JMP證券分析師Jason Butler對鐵木製藥(納斯達克:IRWD)進行了覆蓋,評級為市場表現優於大盤,並宣佈目標價為22美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論